종양약료 전문약사 제도에 대한 국내외 현황 조사와 비교
Certified Oncology Pharmacist in Korea and Abroad: Comparing Systems and Understanding Inconsistencies
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background : Due to the increasing number of patients with cancer and the complexity of anti-cancer drug therapies, it has become important for the pharmacists to develop specialized knowledge and skills to provide enhanced pharmaceutical care for these patients. The concept of certified oncology pharmacist, however, is relatively new in Korea. The objective of this study was to review the certified oncology pharmacist systems in Korea and two advanced countries (the US and Japan) and provide a comparative analysis. Methods : The information related to certified oncology pharmacist system was obtained through the official websites of related organizations in each country. For obtaining the outcomes of pharmaceutical care services provided by certified oncology pharmacists, we explored the related domestic journals and PubMed database. Results : The Korean Society of Health-system Pharmacists (KSHP) conducted the first certified oncology pharmacist examination in 2010 in Korea. To take this examination, completion of a related education course (at least a total of 360 hours) administered by the KSHP is essential. In the United States, the Board Certified Oncology Pharmacist (BCOP) was approved by the board of pharmacy specialty in 1996. In Japan, there are four types of the specialized pharmacist in oncology depending on the organization; Board Certified Pharmacist in Oncology Pharmacy, Japanese Society of Pharmaceutical Health Care and Sciences (JSPHCS)-certified Senior Oncology Pharmacist, JSPHCS-certified Oncology Pharmacist, and Accredited Pharmacist of Ambulatory Cancer Chemotherapy. In the US and Japan, a specialist is required to possess rigorous practical experience as well as academic training. Conclusions : This study provides a deeper understanding of some of the practical issues that need to be addressed for improving the systems of certified oncology pharmacists in Korea.
Abstract
Background : Due to the increasing number of patients with cancer and the complexity of anti-cancer drug therapies, it has become important for the pharmacists to develop specialized knowledge and skills to provide enhanced pharmaceutical care for these patients. The concept of certified oncology pharmacist, however, is relatively new in Korea. The objective of this study was to review the certified oncology pharmacist systems in Korea and two advanced countries (the US and Japan) and provide a comparative analysis. Methods : The information related to certified oncology pharmacist system was obtained through the official websites of related organizations in each country. For obtaining the outcomes of pharmaceutical care services provided by certified oncology pharmacists, we explored the related domestic journals and PubMed database. Results : The Korean Society of Health-system Pharmacists (KSHP) conducted the first certified oncology pharmacist examination in 2010 in Korea. To take this examination, completion of a related education course (at least a total of 360 hours) administered by the KSHP is essential. In the United States, the Board Certified Oncology Pharmacist (BCOP) was approved by the board of pharmacy specialty in 1996. In Japan, there are four types of the specialized pharmacist in oncology depending on the organization; Board Certified Pharmacist in Oncology Pharmacy, Japanese Society of Pharmaceutical Health Care and Sciences (JSPHCS)-certified Senior Oncology Pharmacist, JSPHCS-certified Oncology Pharmacist, and Accredited Pharmacist of Ambulatory Cancer Chemotherapy. In the US and Japan, a specialist is required to possess rigorous practical experience as well as academic training. Conclusions : This study provides a deeper understanding of some of the practical issues that need to be addressed for improving the systems of certified oncology pharmacists in Korea.
참고문헌 (34)
- "2016년 국가암등록통계 참고자료" (2019)[URL]
- "의료법 제77조(전문의), 제78조(전문간호사)" (2019), 보건복지부[URL]
- "전문약사 자격시험" (2019), 병원약학교육연구원[URL]
- "전문약사제도 운영규정 제3조" (2019)[URL]
- "종양약료 전문약사 소개" (2019), 병원약학교육연구원[URL]
- "전문약사 자격시험" (2019), 병원약학교육연구원[URL]
- "전문약사 교육과정의 과목별 이수시간 및 인정 범위" (2019), 병원약학교육연구원[URL]
- "Board of Pharmacy Specialties" (2019)[URL]
- Barry RG, "Our time has arrived!! Board of Pharmaceutical Specialties approves petition to recognize oncology pharmacy practice as a pharmacy specialty", J Oncol Pharm Pract, 2(3), pp.134~135 (1996)
- "Board of Pharmacy Specialties" (2019)[URL]
- Ignoffo R, "Board-Certified Oncology Pharmacists:Their Potential Contribution to Reducing a Shortfall in Oncology Patient Visits", J Oncol Pract, 12(4), pp.e359~e368 (2016)
- "Provider Status in California Paves Way for New Patient-Care Opportunities" (2019)[URL]
- "Growing Trend Toward Specialization, Board Certification" (2019)[URL]
- "North Carolina Pharmacy Rules" (2018)[URL]
- Merten JA, "Utilization of collaborative practice agreements between physicians and pharmacists as a mechanism to increase capacity to care for hematopoietic stem cell transplant recipients", Biol Blood Marrow Transplant, 19(4), pp.509~518 (2013)
- "BPS Fall 2018 Candidate’s Guide updated" (2019)[URL]
- "Oncology Pharmacy; Eligibility Requirements" (2019)[URL]
- "Oncology Pharmacy Specialty Home Study Products co-sponsored by ACCP and ASHP"[URL]
- "ACCP Preparatory Review Resources"[URL]
- "Specialty Recertification"[URL]
- "BCOP Recertification Program Courses"[URL]
- Chung C, "Development and implementation of an interdisciplinary oncology program in a community hospital", Am J Health Syst Pharm, 68(18), pp.1740~1747 (2011)
- Ruder AD, "Is there a benefit to having a clinical oncology pharmacist on staff at a community oncology clinic?", J Oncol Pharm Pract, 17(4), pp.425~432 (2011)
- McKee M, "Impact of clinical pharmacy services on patients in an outpatient chemotherapy academic clinic", J Oncol Pharm Pract, 17(4), pp.387~394 (2011)
- Ishikawa K, "Graduate Programs in Advanced Pharmacy Practice in Oncology in Japan", Am J Pharm Educ, 74(6), pp.111~ (2010)
- "Japanese Society of Hospital Pharmacists" (2007)[URL]
- "Japanese Society of Pharmaceutical Health Care and Sciences" (2001)[URL]
- "National Cancer Center Hospital" (2018)[URL]
- Suzuki S, "The impact of pharmacist certification on the quality of chemotherapy in Japan", Int J Clin Pharm, 38(5), pp.1326~1335 (2016)
- Imamura M, "A Retrospective Study of the Effects of Oncology Pharmacist Participation in Treatment on Therapeutic Outcomes and Medical Costs", Bio Pharm Bull, 40(11), pp.1956~1962 (2017)
- Iihara H, "Pharmacists contribute to the improved efficiency of medical practices in the outpatient cancer chemotherapy clinic", J Eval Clin Pract, 18(4), pp.753~760 (2012)
- Arakawa-Todo M, "Management of adverse events in patients with metastatic renal cell carcinoma treated with sunitinib and clinical outcomes", Anticancer Res, 33(11), pp.5043~5050 (2013)
- 이민정, "다직종 암환자 교육·상담에 대한 설문 개발과 환자 만족도 조사", 한국임상약학회지, 28(2), pp.138~145 (2018), 한국임상약학회[DOI]